(682) 651-1112
Find a Clinical Trial
|
Check Your Eligibility
|
Join Our Clinical Trial Registry
|
Sponsors & CROs
|
Contact Us
Home
Clinical Trials
Find a Clinical Trial
Check Your Eligibility
Join Our Clinical Trial Registry
How Clinical Trial Participation Works
Participant FAQs
Provider Referrals
Areas of Focus
Liver Disease
Metabolic Health & Obesity
Cardiometabolic & Vascular Health
Immunology & Inflammation
Early Phase & Pharmacokinetic (PK) Studies
Sponsors & CROs
Why Sponsors Partner With Evidentis
Capabilities & Infrastructure
Startup & Feasibility
Quality & Compliance
Request Feasibility
Consulting & Advisory Services
Strategic Partnerships
About Us
About Evidentis
Meet The Team
Research & Publications
Careers
Location & Hours
Contact Us
(682) 651-1112
Find a Clinical Trial
|
Check Your Eligibility
|
Join Our Clinical Trial Registry
|
Sponsors & CROs
|
Contact Us
Home
Clinical Trials
Find a Clinical Trial
Check Your Eligibility
Join Our Clinical Trial Registry
How Clinical Trial Participation Works
Participant FAQs
Provider Referrals
Areas of Focus
Liver Disease
Metabolic Health & Obesity
Cardiometabolic & Vascular Health
Immunology & Inflammation
Early Phase & Pharmacokinetic (PK) Studies
Sponsors & CROs
Why Sponsors Partner With Evidentis
Capabilities & Infrastructure
Startup & Feasibility
Quality & Compliance
Request Feasibility
Consulting & Advisory Services
Strategic Partnerships
About Us
About Evidentis
Meet The Team
Research & Publications
Careers
Location & Hours
Contact Us
All Posts
FDA’s Bayes Moment: Why the FDA’s New Guidance Matters for Faster, Smarter Clinical Trials
February 11, 2026
Blog
Adaptive Design
,
Bayesian
,
Bayesian clinical trials
,
Clinical trial innovation
,
Evidentis Clinical Research
,
FDA guidance
,
Liver disease research
In January 2026, the U.S. Food and Drug Administration (FDA) took a meaningful step toward modernizing how...